Moreover, TP53 signature predicted response to chemotherapy; the pCR rate of breast cancer patients with TP53 mt signature was significantly higher than that of breast cancer patients with TP53 wt signature [[24], [25], [26]]. The gene discussed is TP53; the disease is breast cancer.